|
Novartis AG, Switzerland�s largest drugmaker, said all of its late-stage
drugs in development are progressing �well� and asked US and European regulators
to approve its iron treatment Exjade.
�All of the late-stage projects are progressing well in an increasingly challenging industry environment marked by an intensified focus on drug safety,� Joerg Reinhardt, head of development at Basel, Switzerland-based Novartis said in an e-mailed statement. The company is holding a research presentation on it�s early-stage medicines in Boston on Wednesday. New! Sign up for local CML support group meetings in your local community at http://cml.meetup.com Apply for Commercial Real Estate loans online and submit your deal to dozens of hungry lenders in just minutes. Loan programs for all types of business and commercial real estate. Apply anytime at http://realestatezoo.com CML (Chronic Myelogenous Leukemia Support List) --------------------------------- Part Of CMLHope.Com An International Community Of CML Patients For more information: http://cmlhope.com Post Message: [email protected] Subscribe: [EMAIL PROTECTED] Unsubscribe: [EMAIL PROTECTED] Change To No Mail/Web: [EMAIL PROTECTED] Change To Digest: [EMAIL PROTECTED] Change To Email: [EMAIL PROTECTED] List Help: [EMAIL PROTECTED] CML Group Web Site http://groups.yahoo.com/group/CML Yahoo! Groups Links
|
